|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date21 May 1971 |
A Phase 2 Randomised, Double-blind, Placebo-controlled Multiple Ascending Dose Study Evaluate the Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis
The aim of this study is to evaluate the efficacy and safety of Fang yi qing Feng shi granules in subjects with Rheumatoid Arthritis.
100 Clinical Results associated with Maoxiang Group Jilin Pharmacy Co. Ltd.
0 Patents (Medical) associated with Maoxiang Group Jilin Pharmacy Co. Ltd.
100 Deals associated with Maoxiang Group Jilin Pharmacy Co. Ltd.
100 Translational Medicine associated with Maoxiang Group Jilin Pharmacy Co. Ltd.